NuVasive, Inc.
NUVA
NUVA was delisted on the 31st of August, 2023.
177 hedge funds and large institutions have $1.63B invested in NuVasive, Inc. in 2014 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 72 increasing their positions, 60 reducing their positions, and 21 closing their positions.
20% more repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 60
5% less capital invested
Capital invested by funds: $1.72B → $1.63B (-$84.6M)
3% less funds holding
Funds holding: 182 → 177 (-5)
24% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 21
85% less call options, than puts
Call options by funds: $1.02M | Put options by funds: $6.65M
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
+$15.4M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$11.8M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
+$9.86M |
| 4 |
HCM
Hodges Capital Management
Dallas,
Texas
|
+$8.03M |
| 5 |
Goldman Sachs
New York
|
+$7.58M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$11.5M |
| 2 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$6.65M |
| 3 |
MACM
March Altus Capital Management
Greenwich,
Connecticut
|
-$6.29M |
| 4 |
D.E. Shaw & Co
New York
|
-$5.1M |
| 5 |
ICRM
Insight Capital Research & Management
Walnut Creek,
California
|
-$3.38M |
NUVA Hedge Fund Activity: Q2 2014 in Review
177 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in NuVasive, Inc. (NUVA) for Q2 2014, worth a combined $1.63B — down 4.9% from $1.72B a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of NUVA and 16 opened new positions — a net loss of 5 holders — while 60 trimmed existing stakes and 72 added.
The largest buyer was HealthCor Management, adding an estimated $15.4M. The largest seller was JP Morgan Chase, cutting an estimated $11.5M.
- 177 institutional investors held NuVasive, Inc. (NUVA) as of Q2 2014, down from 182 in Q1 2014.
- Funds reported $1.63B of NuVasive, Inc. stock for Q2 2014, down 4.9% quarter-over-quarter.
- 16 funds opened new NuVasive, Inc. positions in Q2 2014 and 21 closed out, a net change of -5 holders.
- The largest NuVasive, Inc. buyer in Q2 2014 was HealthCor Management, an estimated $15.4M added.
- The largest NuVasive, Inc. seller in Q2 2014 was JP Morgan Chase, an estimated $11.5M sold.
Based on aggregated 13F filings for Q2 2014.